Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000313 · ClinicalTrials.gov registry record · Phase 1
Predictive Values of Serotonergic Alterations for Outcome - 2
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 1
- Development phase
NCT00000313 is a Phase 1 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA).
The verdict
NCT00000313, a Phase 1 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
Interventions
- DRUG Fenfluramine
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000313
The ClinicalTrials.gov registry entry for NCT00000313 describes a study currently listed as terminated, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fenfluramine is the first listed.
NCT00000313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000313 about?
NCT00000313 is a clinical study titled "Predictive Values of Serotonergic Alterations for Outcome - 2". The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
What is the current status of trial NCT00000313?
This trial is currently terminated. It is a Phase 1 study.
What interventions are being tested in trial NCT00000313?
The interventions under investigation include: Fenfluramine (DRUG).
Who is sponsoring clinical trial NCT00000313?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.